# Efficacy and Safety of Dapagliflozin in Children With Proteinuria

> **NCT04534270** · PHASE4 · COMPLETED · sponsor: **Children's Hospital of Fudan University** · enrollment: 23 (actual)

## Conditions studied

- Proteinuria

## Interventions

- **DRUG:** Dapagliflozin

## Key facts

- **NCT ID:** NCT04534270
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-06
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-03-30
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2022-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04534270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04534270, "Efficacy and Safety of Dapagliflozin in Children With Proteinuria". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT04534270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*